Voskoboynik, O. Yu., et al. “Synthesis, Anticancer and FGFR1 Inhibitory Activity of isoindolo[2,1-a][1,2,4]triazino[2,3-c]quinazoline Derivatives”. Medical and Clinical Chemistry, no. 1, Apr. 2016, pp. 5-18, doi:10.11603/mcch.2410-681X.2016.v0.i1.6123.